Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
INDIANAPOLIS -- Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares ("Shares") of common stock of POINT ...